These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8083563)

  • 1. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy.
    Castela N; Vermerie N; Chast F; Sauvageon-Martre H; Denis J; Godard V; Goldschmidt P; Pouliquen Y
    J Ocul Pharmacol; 1994; 10(2):439-51. PubMed ID: 8083563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
    Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
    Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
    Kaufman HE; Haw WH
    Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of herpes simplex virus epithelial keratitis.
    Roozbahani M; Hammersmith KM
    Curr Opin Ophthalmol; 2018 Jul; 29(4):360-364. PubMed ID: 29697435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers).
    Croxtall JD
    Drugs; 2011 Mar; 71(5):603-10. PubMed ID: 21443283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.
    Hoh HB; Hurley C; Claoue C; Viswalingham M; Easty DL; Goldschmidt P; Collum LM
    Br J Ophthalmol; 1996 Feb; 80(2):140-3. PubMed ID: 8814744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
    Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications.
    Deai T; Fukuda M; Hibino T; Higaki S; Hayashi K; Shimomura Y
    Cornea; 2004 Mar; 23(2):125-8. PubMed ID: 15075880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.
    Heiligenhaus A; Steuhl KP
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):435-8. PubMed ID: 10333113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
    Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
    Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of HSV1 ocular infections using quantitative real-time PCR results.
    Hlinomazová Z; Loukotová V; Horáčková M; Šerý O
    Acta Ophthalmol; 2012 Aug; 90(5):456-60. PubMed ID: 20553233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications.
    Chou TY; Hong BY
    Ther Clin Risk Manag; 2014; 10():665-81. PubMed ID: 25187721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis.
    Kaufman HE; Varnell ED; Thompson HW
    Arch Ophthalmol; 1998 Jun; 116(6):777-80. PubMed ID: 9639447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.
    Wang X; Wang L; Wu N; Ma X; Xu J
    Chin Med J (Engl); 2015 Jan; 128(1):46-50. PubMed ID: 25563312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
    Carter SB; Cohen EJ
    Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
    Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
    Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
    Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical ganciclovir in the treatment of acute herpetic keratitis.
    Tabbara KF; Al Balushi N
    Clin Ophthalmol; 2010 Aug; 4():905-12. PubMed ID: 20823931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.